Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), McKesson (MCK)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX – Research Report) and ...
McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript
Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Rachel ...
McKesson projects $32.55-$32.95 adjusted EPS for FY25, driven by specialty growth
Vitalone confirmed the company raised its adjusted EPS guidance to a range of $32.55 to $32.95 for fiscal 2025, representing 19%-20% year-over-year growth. Management raised full-year guidance for ...
McKesson Exceeds EPS, Q3 Profit Surges
With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...
McKesson to Acquire Eye-Care Platform; Posts Higher 3Q Revenue, Profit
McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...
StockStory.org on MSN15h
McKesson (NYSE:MCK) Misses Q4 Sales Targets
Healthcare distributor and services company McKesson (NYSE:MCK) in Q4 CY2024, but sales rose 17.8% year on year to $95.29 ...
McKesson misses third-quarter revenue estimates
Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its ...
McKesson raises, narrows FY25 adjusted EPS view to $32.55-$32.95 from $32.40-$33
Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...
McKesson, AmerisourceBergen Win Bid to Toss Price-Fixing Claims
McKesson Corp. and AmerisourceBergen Drug Corp. are among the drug distributors that won a bid to toss antitrust claims that they colluded to inflate prices of several generic pharmaceutical products.
McKesson: Fiscal Q3 Earnings Snapshot
IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal third-quarter earnings of $879 million. The Irving, Texas-based company said it had profit of $6.95 per ...
Cencora Enjoys Growth Momentum From GLP-1s, Healthy Utilization Trends, and Growing Specialty Assets
Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...
McKesson (MCK) Q3 2025 Earnings Call Transcript
Welcome to McKesson's third quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being ...